Physician profile
David C Pan
NPI 1912932740
$54,037.02
in general payments reported to CMS, 2019-2025
42 companies · $3,461 in 2025
The $3,461 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,077 · 2020: $4,252 · 2021: $15K · 2022: $14K · 2023: $9,764 · 2024: $2,891 · 2025: $3,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,505 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,600 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,505.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,600.00 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $34,689.42 | 2019-2024 | Xarelto |
| Abbott Laboratories | $4,799.68 | 2019-2025 | Assurity, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Novartis Pharmaceuticals Corporation | $1,710.67 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,414.57 | 2019-2025 | Lifevest |
| Medtronic, INC. | $1,410.35 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Reveal Linq |
| Amgen INC. | $1,094.49 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $1,092.49 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,051.98 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $754.20 | 2022-2025 | Verquvo, Winrevair |
| Sanofi-Aventis U.S. LLC | $703.61 | 2019-2023 | |
| Pfizer INC. | $548.05 | 2019-2025 | |
| Biotronik INC. | $443.43 | 2019-2025 | Orsiro Mission, Nhancer Rx, Pk Papyrus |
| Alnylam Pharmaceuticals INC. | $363.91 | 2022-2025 | Amvuttra |
| Medtronic Vascular, INC. | $360.51 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $315.40 | 2022-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $253.67 | 2022-2025 | Wainua, Farxiga |
| Bardy Diagnostics, INC. | $253.01 | 2020-2022 | |
| Scpharmaceuticals INC. | $212.44 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $211.60 | 2019-2025 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $181.52 | 2019-2025 | Evkeeza |
| Amarin Pharma, INC. | $181.50 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $174.80 | 2022-2023 | Optimizer |
| Heartflow, INC. | $173.74 | 2022-2024 | Ffrct |
| Edwards Lifesciences Corporation | $173.73 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kestra Medical Technology Services, INC. | $155.44 | 2022-2023 | Assure Wcd |
| Baxter Healthcare | $151.71 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Abiomed | $149.64 | 2025 | |
| Boston Scientific Corporation | $146.26 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $143.37 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $135.85 | 2025 | Attruby |
| Kiniksa Pharmaceuticals, Ltd. | $127.37 | 2022-2023 | Arcalyst |
| Shockwave Medical, INC | $126.04 | 2025 | |
| Zoll Respicardia, INC. | $104.51 | 2025 | Remede System |
| Cvrx, INC. | $52.88 | 2022-2024 | Barostim Neo System |
| Astellas Pharma US INC | $51.96 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $27.40 | 2019-2021 | |
| Cmp Pharma, INC. | $23.23 | 2022 | |
| Lundbeck LLC | $22.20 | 2020 | |
| Cardiva Medical, INC. | $14.34 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Esperion Therapeutics, INC. | $13.17 | 2021 | |
| Cranial Technologies, INC | $11.95 | 2019 | |
| Atricure, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.